CN1883469A - 一种含有维生素a和维生素e的眼用微乳及其制备方法 - Google Patents
一种含有维生素a和维生素e的眼用微乳及其制备方法 Download PDFInfo
- Publication number
- CN1883469A CN1883469A CN 200610013874 CN200610013874A CN1883469A CN 1883469 A CN1883469 A CN 1883469A CN 200610013874 CN200610013874 CN 200610013874 CN 200610013874 A CN200610013874 A CN 200610013874A CN 1883469 A CN1883469 A CN 1883469A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- microemulsion
- tocopherol
- alpha
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title claims abstract description 67
- 239000004530 micro-emulsion Substances 0.000 title claims abstract description 45
- 229930003427 Vitamin E Natural products 0.000 title claims abstract description 30
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 229940046009 vitamin E Drugs 0.000 title claims abstract description 30
- 235000019165 vitamin E Nutrition 0.000 title claims abstract description 30
- 239000011709 vitamin E Substances 0.000 title claims abstract description 30
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 title claims abstract description 26
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 title claims abstract description 25
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 title claims abstract description 20
- 235000019155 vitamin A Nutrition 0.000 title claims abstract description 20
- 239000011719 vitamin A Substances 0.000 title claims abstract description 20
- 229940045997 vitamin a Drugs 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000008213 purified water Substances 0.000 claims abstract description 27
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- 239000012071 phase Substances 0.000 claims abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 22
- 229920002125 Sokalan® Polymers 0.000 claims description 17
- -1 retinol ester Chemical class 0.000 claims description 16
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 15
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 15
- 239000011769 retinyl palmitate Substances 0.000 claims description 15
- 229940108325 retinyl palmitate Drugs 0.000 claims description 15
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 13
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 12
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 12
- 229960000984 tocofersolan Drugs 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 10
- 235000019198 oils Nutrition 0.000 claims description 10
- 210000003022 colostrum Anatomy 0.000 claims description 9
- 235000021277 colostrum Nutrition 0.000 claims description 9
- 238000004945 emulsification Methods 0.000 claims description 9
- 229960001727 tretinoin Drugs 0.000 claims description 9
- 239000002076 α-tocopherol Substances 0.000 claims description 9
- 235000004835 α-tocopherol Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000012982 microporous membrane Substances 0.000 claims description 8
- 229940087168 alpha tocopherol Drugs 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 6
- 235000020944 retinol Nutrition 0.000 claims description 5
- 239000011607 retinol Substances 0.000 claims description 5
- 229960003471 retinol Drugs 0.000 claims description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 claims description 4
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 4
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 3
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000004584 polyacrylic acid Substances 0.000 claims description 3
- 229930002330 retinoic acid Natural products 0.000 claims description 3
- IQXJCCZJOIKIAD-UHFFFAOYSA-N 1-(2-methoxyethoxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOCCOC IQXJCCZJOIKIAD-UHFFFAOYSA-N 0.000 claims description 2
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- 241001597008 Nomeidae Species 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 229960001574 benzoxonium chloride Drugs 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 229950009789 cetomacrogol 1000 Drugs 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 150000002357 guanidines Chemical class 0.000 claims description 2
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 238000011017 operating method Methods 0.000 claims description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- PXGPLTODNUVGFL-JZFBHDEDSA-N prostaglandin F2beta Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H](O)[C@@H]1C\C=C/CCCC(O)=O PXGPLTODNUVGFL-JZFBHDEDSA-N 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 229960000342 retinol acetate Drugs 0.000 claims description 2
- 235000019173 retinyl acetate Nutrition 0.000 claims description 2
- 239000011770 retinyl acetate Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940103494 thiosalicylic acid Drugs 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 229930014626 natural product Natural products 0.000 claims 1
- 150000003772 α-tocopherols Chemical class 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 206010013774 Dry eye Diseases 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 239000002318 adhesion promoter Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- 229960001631 carbomer Drugs 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 239000000607 artificial tear Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 208000005494 xerophthalmia Diseases 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- ZBCATMYQYDCTIZ-UHFFFAOYSA-N 4-methylcatechol Chemical compound CC1=CC=C(O)C(O)=C1 ZBCATMYQYDCTIZ-UHFFFAOYSA-N 0.000 description 2
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 229940044519 poloxamer 188 Drugs 0.000 description 2
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940030216 hypotears Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000010494 opalescence Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003900 succinic acid esters Chemical class 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000002266 vitamin A derivatives Chemical class 0.000 description 1
- 125000001020 α-tocopherol group Chemical group 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100138746A CN1883469B (zh) | 2006-05-26 | 2006-05-26 | 一种含有维生素a和维生素e的眼用微乳及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100138746A CN1883469B (zh) | 2006-05-26 | 2006-05-26 | 一种含有维生素a和维生素e的眼用微乳及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1883469A true CN1883469A (zh) | 2006-12-27 |
CN1883469B CN1883469B (zh) | 2011-07-20 |
Family
ID=37581852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100138746A Expired - Fee Related CN1883469B (zh) | 2006-05-26 | 2006-05-26 | 一种含有维生素a和维生素e的眼用微乳及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1883469B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520009A (zh) * | 2013-09-27 | 2014-01-22 | 华南理工大学 | 载水杨酸的维生素e微乳液及其制备方法 |
CN104203283A (zh) * | 2012-04-13 | 2014-12-10 | 株式会社爱茉莉太平洋 | 纳米乳液组合物及其制备方法 |
CN104887781A (zh) * | 2015-06-18 | 2015-09-09 | 中南大学 | 一种用于缓解干眼症的眼药水及其制备方法 |
CN112933118A (zh) * | 2019-11-19 | 2021-06-11 | 强生消费者公司 | 用于治疗眼睛的组合物和方法 |
CN115463089A (zh) * | 2022-08-30 | 2022-12-13 | 宁夏医科大学 | 一种治疗干眼症的眼用微乳及其制备方法与应用 |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1048868C (zh) * | 1994-11-30 | 2000-02-02 | 王万梅 | 鱼肝油乳及其制备方法 |
DE19511322C2 (de) * | 1995-03-28 | 1999-09-02 | Mann Gerhard Chem Pharm Fab | Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung |
JP2002332225A (ja) * | 2001-05-09 | 2002-11-22 | Lion Corp | 眼科用組成物 |
-
2006
- 2006-05-26 CN CN2006100138746A patent/CN1883469B/zh not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104203283A (zh) * | 2012-04-13 | 2014-12-10 | 株式会社爱茉莉太平洋 | 纳米乳液组合物及其制备方法 |
CN104203283B (zh) * | 2012-04-13 | 2018-01-26 | 株式会社爱茉莉太平洋 | 纳米乳液组合物及其制备方法 |
CN103520009A (zh) * | 2013-09-27 | 2014-01-22 | 华南理工大学 | 载水杨酸的维生素e微乳液及其制备方法 |
CN103520009B (zh) * | 2013-09-27 | 2016-04-13 | 华南理工大学 | 载水杨酸的维生素e微乳液及其制备方法 |
CN104887781A (zh) * | 2015-06-18 | 2015-09-09 | 中南大学 | 一种用于缓解干眼症的眼药水及其制备方法 |
CN104887781B (zh) * | 2015-06-18 | 2018-06-19 | 中南大学 | 一种用于缓解干眼症的眼药水及其制备方法 |
CN112933118A (zh) * | 2019-11-19 | 2021-06-11 | 强生消费者公司 | 用于治疗眼睛的组合物和方法 |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
CN115463089A (zh) * | 2022-08-30 | 2022-12-13 | 宁夏医科大学 | 一种治疗干眼症的眼用微乳及其制备方法与应用 |
CN115463089B (zh) * | 2022-08-30 | 2023-10-20 | 宁夏医科大学 | 一种治疗干眼症的眼用微乳及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1883469B (zh) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104619314B (zh) | 包含半氟化烷烃的混合物的组合物 | |
KR101677308B1 (ko) | 오메가-3 및 오메가-6 다가 불포화 지방산계 안과용 조성물 | |
CN101028240B (zh) | 眼用微乳/亚微乳原位凝胶制剂及其制备方法 | |
CN104755073B (zh) | 半氟化烷烃组合物 | |
CN100478025C (zh) | 一种环孢菌素a眼用微乳制剂及其制备方法 | |
AU2009302167B2 (en) | Composition and method for treating dry eye syndrome | |
CN103533962B (zh) | 一种眼用组合物 | |
US11903986B2 (en) | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye | |
RU2697844C2 (ru) | Стабилизированные композиции для офтальмологического применения, содержащие омега-3-кислоты | |
US20210085603A1 (en) | Microemulsion for opthalmic drug delivery | |
KR20100067684A (ko) | 약물 전달을 위한 비히클로서의 수불혼화성 물질 | |
WO2018212955A1 (en) | Nanoemulsions with anti-inflammatiory activity | |
CN1883469A (zh) | 一种含有维生素a和维生素e的眼用微乳及其制备方法 | |
CN106061490A (zh) | 一种治疗和预防眼部疾病症状或体征的方法及组合物 | |
CN1053807C (zh) | 维生素e点眼剂 | |
CN113577024B (zh) | 一种眼用组合物及其制备方法和应用 | |
CN100393303C (zh) | 维生素a脂质体人工泪滴眼液 | |
CN100562340C (zh) | 一种微乳型人工泪液 | |
CN112367981B (zh) | 用于将药剂无创地持续递送至眼部的液体储库 | |
CN1651090A (zh) | 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法 | |
CN100335050C (zh) | 水飞蓟宾的药物组合物 | |
CN115463089B (zh) | 一种治疗干眼症的眼用微乳及其制备方法与应用 | |
US20240180826A1 (en) | Opthalmic Compositions for Dry Eye Treatment and Methods of Manufacture of the Same | |
CN1204922C (zh) | 新的眼科用组合物 | |
WO2023119220A1 (en) | A compostion for treating ocular infections and a method of preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090123 Address after: Wuhan Gutian City Qiaokou District Road No. 5 Applicant after: Grand Pharma (China) Co.,Ltd. Address before: Tianjin City, Hexi District Zijin Shanxi Lu Bin Shui Nan Li 46-309 Applicant before: Zhu Qiwan |
|
ASS | Succession or assignment of patent right |
Owner name: WUHAN YUANDA PHARMACEUTICAL GROUP CO.,LTD. Free format text: FORMER OWNER: ZHU ZHUWAN Effective date: 20090123 |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: GRANDPHARMA (CHINA) CO., LTD. Free format text: FORMER NAME: WUHAN GRAND PHARMACEUTICAL GROUP CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 430035 Gutian road in Hubei province Wuhan City Qiaokou District No. 5 Patentee after: GRAND PHARMA (CHINA) CO.,LTD. Address before: 430035 Gutian road in Hubei province Wuhan City Qiaokou District No. 5 Patentee before: Grand Pharma (China) Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20061227 Assignee: HUBEI GRAND EVERYDAY BRIGHT EYES PHARMACEUTICAL CO.,LTD. Assignor: GRAND PHARMA (CHINA) CO.,LTD. Contract record no.: 2013420000164 Denomination of invention: An ocular microemulsion containing Vitamin A and Vitamin E and preparation method thereof Granted publication date: 20110720 License type: Exclusive License Record date: 20130926 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 |